The research report provides an in-depth evaluation of the Global Carrier Screening Market and helps the market participants intensify their footprints in the industry. The report gives a detailed analysis concentrated on the critical market dynamics such as drivers, restraints, trends, and growth opportunities to assist businesses to prepare for any challenges they might encounter in the forecast period. It also offers a regional analysis of the global Carrier Screening market to explore possible growth prospects available in different parts of the world. The competitive landscape is broadly evaluated alongside the company profiles of key players engaged in the global Carrier Screening market. The report offers a detailed statistical evaluation and accurate market data, viz., market share, CAGR, gross margin, revenue, consumption, production, and sales.
Read more@ https://www.emergenresearch.com/industry-report/carrier-screening-market
Key Highlights From The Report.
In November 2019, Asuragen, a molecular diagnostics company based out of the U.S. launched the AmplideX® PCR/CE SMN1/2 Plus Kit. The technology helps in the early detection of variants associated with SMN1 gene duplication events as well as quantify numbers related to SMN1 and SMN2. By providing results from a single PCR reaction, the technology helps to increase efficiency by reducing time and effort.
The growth across the carrier screening bifurcation is estimated to continue to contribute to the growth of the market until 2030 due to the fact that, with this approach, tests for multiple genetic diseases can be carried out at once. The dominance of the market segment is also because of the heavy utilization of the next-generation sequencing (NGS) technique for genetic disease screening.
Over the forecast period, the DNA sequencing segment is anticipated to witness the highest market share in terms of revenue in the carrier screening market because of the number of patents rising on an incremental scale across European and North American regions. Additionally, the awareness regarding the advantages of diagnosing critical diseases early is increasing, thereby driving the growth of the market.
In terms of revenue, North America held the largest market share in 2019 which can be attributed to the increasing number of tests conducted in order to analyze whether an individual is carrying the gene for an inherited disease. The major competitors across the globe are emphasising on the development of healthcare infrastructure. Over the coming years, Asia Pacific is expected to register the highest CAGR of 18.4% throughout the forecasted period as people in India, China, and Australia are becoming aware of genetic diseases and screening tests.
Key participants MedGenome Inc., Luminex Corporation, Illumina Inc., Otogenetics Corporation, Myriad Genetics Inc., Thermo Fisher Scientific Inc., Natera Inc., Gene By Gene Ltd., Corporation of America Holdings, and Mount Sinai Genomics Inc., among others.
Interested in this report? Get your FREE sample now! https://www.emergenresearch.com/request-sample/235
For the purpose of this report, Emergen Research has segmented the Global Carrier Screening Market on the technology, end-user, medical condition, and region:
Technology Outlook (Revenue, USD Billion; 2017-2027)
DNA Sequencing
Polymerase Chain Reaction
Microarrays
Others
End-User Outlook (Revenue, USD Billion; 2017-2027)
Hospitals
Reference Laboratories
Physician Offices and Clinics
Others
Medical Condition Outlook (Revenue, USD Billion; 2017-2027)
Pulmonary Conditions
Hematological Conditions
Neurological Conditions
Others
Here are the questions we answer...
At what rate will the Carrier Screening Market grow? What will be the value of the market in 2027?
What are the key technologies driving the Carrier Screening Market?
What would be the impact of Carrier Screening Market across different regions?
What are the strategies adopted by players to enter the APAC region?
What is the critical application of the Carrier Screening Market in the different sectors?
What are future growth strategies in the market?
